Delivery Order SPE2DB22D6029-SPE2DB24FU0CH
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,859.70, is for the supply of OPZELURA 1.5% Cream in 60 gram quantities. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream in 60 gram units, with a ceiling value of $6,365.08 and a performance period through June 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $1,539.12 and a completion date of April 1, 2024. This contract is a firm fixed-price delivery order, with no set-aside requirements. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product OPZELURA 1.5% Cream 60GM. The contract has a ceiling value of $12,366.18 and an ultimate completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product, with a ceiling value of $10,421.76 and a completion date of June 4, 2025. The contract is not set aside and was awarded on June 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and this...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,919.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OPZELURA 1.5% Cream 60GM. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a ceiling value of $3,648.46 and a performance period through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,653.82, is for the supply of OPZELURA 1.5% cream, a 60 gram topical medication. The contract has an ultimate completion date of April 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a $6,348.98 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream (60 gm) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% cream in 60 gram units, with a total ceiling value of $3,528.06 and a period of performance through June 18, 2025. The contract is not set aside and was awarded on June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0CHDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a potential value of $5,975.76 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The current delivery order is issued under this IDC. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 2/26/24 |